Voloridge Investment Management
PCRX icon

Voloridge Investment Management’s Pacira BioSciences PCRX Stock Holding History

Voloridge Investment Management’s Portfolio PCRX Stock Details PCRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-19,762
Closed -$447K – 1018
2026
Q1 		$447K Sell
19,762
-214,680
-92% -$4.77M ﹤0.01% 949
2025
Q4 		$6.07M Sell
234,442
-28,281
-11% -$672K 0.02% 716
2025
Q3 		$6.77M Buy
262,723
+127,181
+94% +$3.12M 0.02% 652
2025
Q2 		$3.24M Sell
135,542
-396,432
-75% -$9.99M 0.01% 868
2025
Q1 		$13.2M Buy
531,974
+415,825
+358% +$9.96M 0.05% 478
2024
Q4 		$2.19M Buy
116,149
+65,467
+129% +$1.15M 0.01% 928
2024
Q3 		$763K Sell
50,682
-13,985
-22% -$239K ﹤0.01% 1050
2024
Q2 		$1.85M Sell
64,667
-123,777
-66% -$3.52M 0.01% 963
2024
Q1 		$5.51M Buy
188,444
+113,990
+153% +$3.5M 0.02% 642
2023
Q4 		$2.51M Buy
74,454
+40,044
+116% +$1.17M 0.01% 778
2023
Q3 		$1.06M Buy
+34,410
New +$1.24M 0.01% 1083
2021
Q4 		– Sell
-80,849
Closed -$4.53M – 1781
2021
Q3 		$4.53M Buy
80,849
+46,562
+136% +$2.68M 0.03% 723
2021
Q2 		$2.08M Buy
34,287
+30,481
+801% +$1.93M 0.01% 981
2021
Q1 		$267K Sell
3,806
-109,886
-97% -$7.85M ﹤0.01% 1272
2020
Q4 		$6.8M Buy
113,692
+3,235
+3% +$189K 0.06% 375
2020
Q3 		$6.64M Buy
+110,457
New +$6.42M 0.06% 366
2020
Q1 		– Sell
-7,513
Closed -$340K – 1319
2019
Q4 		$340K Buy
+7,513
New +$319K 0.01% 901
2019
Q2 		– Sell
-14,903
Closed -$567K – 993
2019
Q1 		$567K Sell
14,903
-12,313
-45% -$481K 0.02% 633
2018
Q4 		$1.17M Sell
27,216
-28,910
-52% -$1.35M 0.05% 252
2018
Q3 		$2.76M Buy
+56,126
New +$2.43M 0.06% 187

Other funds holding PCRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DPCM
Doma Perpetual Capital Management Miami, Florida $431M AUM 13.21% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Voloridge Investment Management's PCRX Position: Q2 2026 in Review

Voloridge Investment Management sold out of Pacira BioSciences (PCRX) in Q2 2026, closing a stake of 19,762 shares — an estimated $447K sold.

Voloridge Investment Management first reported a position in PCRX in Q3 2018 and held it in 20 quarters. The position peaked at $13.2M in Q1 2025. 253 funds tracked by Wall St. Rank hold PCRX as of Q2 2026.

  • Voloridge Investment Management reported no remaining Pacira BioSciences position as of Q2 2026 after selling out during the quarter.
  • Voloridge Investment Management sold 19,762 Pacira BioSciences shares in Q2 2026, an estimated $447K.
  • Voloridge Investment Management first reported a position in Pacira BioSciences in Q3 2018 and held it in 20 quarters.
  • Voloridge Investment Management's Pacira BioSciences position peaked at $13.2M in Q1 2025.
  • 253 funds tracked by Wall St. Rank held Pacira BioSciences as of Q2 2026.

Based on Voloridge Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.